The early oncological effect of extended pelvic lymph node dissection in men with at PSMA PET/CT N0M0 intermediate/high-risk prostate cancer - an international cohort study

被引：0
|
作者：
Van Leeuwen, P. J. [1 ]
Berrens, A-C [1 ]
Vis, A. [2 ]
Yaxley, J. [3 ,5 ]
Meijer, D. [2 ]
Siriwardana, A. [3 ]
Wit, E. [1 ]
Van der Noort, V. [4 ]
Morton, A. [3 ]
Franklin, A. [3 ]
Yaxley, J. [3 ,5 ]
Wong, D. [6 ]
Goughlin, G. [6 ]
Gianduzzo, T. [6 ]
Kua, B. [6 ]
Emmett, L. [7 ]
Zuur, L. [1 ]
Van der Poel, H. [1 ]
Roberts, M. [3 ]
机构：
[1] Netherlands Canc Inst, Dept Urol, Amsterdam, Netherlands
[2] Amsterdam Univ Med Ctr Locat VUmc, Dept Urol, Amsterdam, Netherlands
[3] Royal Brisbane & Womens Hosp, Dept Urol, Brisbane, Qld, Australia
[4] Netherlands Canc Inst, Dept Stat, Amsterdam, Netherlands
[5] Aquesta Pathol, Dept Pathol, Brisbane, Qld, Australia
[6] Wesley Hosp, Dept Urol, Brisbane, Qld, Australia
[7] St Vincents Hosp, Dept Nucl Med, Sydney, NSW, Australia
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0423
引用
收藏
页码：S1263 / S1264
页数：2
相关论文
共 50 条
  • [1] Impact of Pelvic Lymph Node Dissection on Early Oncological Outcomes in Intermediate-Risk Prostate Cancer Patients With Node-Negative PSMA PET
    Esen, Baris
    Seymen, Hulya
    Armutlu, Ayse
    Koseoglu, Ersin
    Aykanat, Ibrahim Can
    Zoroglu, Hatice
    Canda, Abdullah Erdem
    Kordan, Yakup
    Balbay, Mevlana Derya
    Baydar, Dilek Ertoy
    Demirkol, Mehmet Onur
    Tilki, Derya
    Esen, Tarik
    PROSTATE, 2025,
  • [2] Laparoscopic extended pelvic lymph node dissection for high-risk prostate cancer
    Wyler, Stephen F.
    Sulser, Tullio
    Seifert, Hans-Helge
    Ruszat, Robin
    Forster, Thomas H.
    Gasser, Thomas C.
    Bachmann, Alexander
    UROLOGY, 2006, 68 (04) : 883 - 887
  • [3] 18F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer
    H. Kjölhede
    G. Ahlgren
    H. Almquist
    F. Liedberg
    K. Lyttkens
    T. Ohlsson
    O. Bratt
    World Journal of Urology, 2014, 32 : 965 - 970
  • [4] 18F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer
    Kjolhede, H.
    Ahlgren, G.
    Almquist, H.
    Liedberg, F.
    Lyttkens, K.
    Ohlsson, T.
    Bratt, O.
    WORLD JOURNAL OF UROLOGY, 2014, 32 (04) : 965 - 970
  • [5] 68Ga-PSMA-11 PET has the potential to improve patient selection for extended pelvic lymph node dissection in intermediate to high-risk prostate cancer
    Daniela A. Ferraro
    Urs J. Muehlematter
    Helena I. Garcia Schüler
    Niels J. Rupp
    Martin Huellner
    Michael Messerli
    Jan Hendrik Rüschoff
    Edwin E. G. W. ter Voert
    Thomas Hermanns
    Irene A. Burger
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 147 - 159
  • [6] 68Ga-PSMA-11 PET has the potential to improve patient selection for extended pelvic lymph node dissection in intermediate to high-risk prostate cancer
    Ferraro, Daniela A.
    Muehlematter, Urs J.
    Garcia Schuler, Helena I.
    Rupp, Niels J.
    Huellner, Martin
    Messerli, Michael
    Ruschoff, Jan Hendrik
    ter Voert, Edwin E. G. W.
    Hermanns, Thomas
    Burger, Irene A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (01) : 147 - 159
  • [7] IMPACT OF EXTENDED VS LIMITED PELVIC LYMPH NODE DISSECTION ON BIOCHEMICAL RECURRENCE IN INTERMEDIATE AND HIGH-RISK PROSTATE CANCER
    Hinojosa-Gonzalez, David E.
    Nolazco, Jose I.
    Saffati, Gal
    Kronstedt, Shane
    Jones, Jeffrey A.
    Kadmon, Dov
    Badal, Justin
    Slawin, Jeremy R.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E955 - E956
  • [8] Diagnostic accuracy of PSMA-PET-CT for pelvic lymph node staging in men with prostate cancer undergoing radical prostatectomy and pelvic lymph node dissection
    Grogg, J. B.
    Affentranger, A.
    Wettstein, M. S.
    Kaufmann, B.
    Grossmann, N. C.
    Eberli, D.
    Poyet, C.
    Hermanns, T.
    Fankhauser, C. D.
    EUROPEAN UROLOGY, 2021, 79 : S1168 - S1168
  • [9] Negative PSMA PET can be used to avoid unnecessary pelvic lymph node dissection in intermediate risk prostate cancer
    Incesu, Reha-Baris
    Preisser, Felix
    Nohe, Florian
    Maurer, Tobias
    Graefen, Markus
    Tilki, Derya
    PROSTATE CANCER AND PROSTATIC DISEASES, 2025,
  • [10] ONCOLOGICAL OUTCOMES OF UNFAVORABLE INTERMEDIATE-RISK IS COMPARABLE TO HIGH-RISK LOCALIZED PROSTATE CANCER IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION
    Ahallal, Youness
    Benarroche, Davy
    Zanettini, Luis Felipe Snel
    Colau, Alexandre
    Charbonnier, Clement
    Cote, Jean-Francois
    Guillonneau, Bertrand
    JOURNAL OF UROLOGY, 2018, 199 (04): : E819 - E819
12345